AnaptysBio
AnaptysBio develops antibody therapeutics based on somatic hypermutation. Learn more
Launch date
Employees
Market cap
AUD1.9b
Enterprise valuation
AUD1.4b (Public information from Sep 2024)
Share price
$36.57 ANAB
San Diego California (HQ)
Authorizing premium user...